Archive for the ‘Immune System’ Category

EMEA Recommends Authorisation Of First Pre-Pandemic Influenza Vaccine, Europe

Friday, February 22nd, 2008

The European Medicines Agency recommended the authorisation of the first 'pre-pandemic vaccine' for humans against influenza caused by the H5N1 virus. This is an avian influenza ('bird flu') virus strain that has the potential to evolve into a pandemic influenza virus affecting humans. Prepandrix, from GlaxoSmithKline Biologicals, is a pre-pandemic vaccine ...

Therapy Stimulates Recovery Of The Thymus Gland

Friday, February 22nd, 2008

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) and the University of California, San Francisco (UCSF) have found that therapy can be used to stimulate the production of vital immune cells, called "T- cells," in adults with HIV infection. HIV disease destroys T-cells, leading to collapse of the immune ...

New Novartis Research Institute First To Focus On Innovative Vaccines For The Developing World

Friday, February 22nd, 2008

Novartis announced the opening of a new research institute in Siena with a nonprofit mission to exclusively focus on the development of vaccines for diseases of the developing world. The Novartis Vaccines Institute for Global Health (NVGH) is the first institute of its kind to be set up by a ...

Innate Immune Response Fine-Tuned By Single MicroRNA

Wednesday, February 20th, 2008

Findings: A single microRNA, microRNA-223, in mice controls the production and activation of granulocytes, white blood cells essential for host defense against invading pathogens. Relevance: This is the first microRNA shown to play a crucial role in the innate immune response. Absence of microRNA-223 increased the production, differentiation and activation of ...

Allergen Immunotherapy Evolves As Faster, Safer And Longer Lasting Treatment

Monday, November 12th, 2007

Time tested for a century, allergen immunotherapy has evolved into revolutionary methods of administration, as well as faster, safer and longer lasting treatments according to the latest research presented at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Dallas. Recent studies have shown subcutaneous immunotherapy, ...

The AAAS Honors Members As Fellows For Distinction In Science

Monday, October 29th, 2007

Ten renowned scientists and educators at Yale have been named as Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon members of the organization by their peers. The AAAS honors members as Fellows in recognition of their distinguished efforts to advance science or its applications. ...

Government Of Madagascar And Coalition Of Global Partners Launch Measles And Malaria Prevention Campaign

Tuesday, October 23rd, 2007

The government of Madagascar, in collaboration with international partners, is launching a national health campaign to vaccinate more than 2.8 million children against measles and distribute more than 1.5 million insecticide-treated mosquito nets to prevent the spread of malaria-diseases which take the lives of more than 1 million African children ...

Nanoparticle Technology Enables Improved, Cost Effective Vaccine

Wednesday, September 19th, 2007

Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies. Described in an article appearing online September 16 in the journal ...

Body’s Own DNA Coupled With A Peptide Ignites Immune Response Usually Aimed At Fighting Infection

Wednesday, September 19th, 2007

A human peptide that acts as a natural antibiotic against invading microbes can also bind to the body's own DNA and trigger an immune response in the absence of an infection, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in an ...